Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-038549
Date:2021-09-28
Issuer: TERNS PHARMACEUTICALS, INC. (TERN)
Original Submission Date:

Reporting Person:

VIGNOLA MARK J.
C/O TERNS PHARMACEUTICALS, INC.
1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY, CA 94404

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 10.72 2021-09-28 deemed execution date A 120,000 (a) 2031-09-28 common stock 120,000 $10.72 120,000 direct
Footnotes
IDfootnote
f1 25% of the shares subject to the option vest on the first anniversary measured from september 28, 2021 (the "vesting commencement date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the vesting commencement date.
WhaleWisdom Logo

Elevate your investments